Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production

The FDA has announced its approval of Sanofi’s Admelog (insulin lispro), the first follow-on biologic version of Eli Lilly’s Humalog.
It seems that no matter how much bad press comes their way, certain pharmaceutical companies are more than happy to take a little heat to make quick...
A team of researchers at the University of Maryland School of Medicine (UMSOM) has been assessing the effectiveness of a single high-dose live...
Sanofi has announced a recall of 12,380 syringes of its Synvisc-One product for the treatment of osteoarthritis, after it was noted that a particular...

Features

Andrew Lane, Executive Vice President of Established Pharmaceuticals at Abbott, discusses the key steps to be taken when reaching out to the...

Appointments

Shortly following its announcement of...

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches